Fig. 3.

Clinical correlations of risk score and development of the nomogram in the GSE10846 dataset. A Survival curve of patients in the high- and low-risk groups in the GSE10846 immunotherapy cohort (232 patients who had received R-CHOP treatment). B–H Relationships between the risk score and clinicopathological features (including age, ECOG status, stage, LDH level, IPI score, gender and extranodal sites). 305 patients with complete clinicopathological features from the GSE10846 dataset were analyzed. The distance of both ends of boxes represents the interquartile range of values and the thick line represents the median value. I Univariate and multivariate analyses revealed the risk score was an independent prognostic factor for DLBCL patients. J Nomogram for predicting the 3- and 5-year OS of DLBCL patients. K Calibration curves of the nomogram for OS prediction at 3- and 5- year. L ROC curves indicating the comparisons of the risk score and the IPI score in predicting 1-year OS